Picture of Shenzhen Hepalink Pharmaceutical Co logo

9989 Shenzhen Hepalink Pharmaceutical Co News Story

0.000.00%
hk flag iconLast trade - 00:00
HealthcareAdventurousMid CapNeutral

Brief: Shenzhen Hepalink Pharmaceutical Sees HY Net Profit Attributable RMB642.28 Mln To RMB734.82 Mln

July 12 (Reuters) - Shenzhen Hepalink Pharmaceutical
Group Co Ltd  002399.SZ :
    * SEES HY NET PROFIT ATTRIBUTABLE BETWEEN RMB642.28 MILLION
TO 
RMB734.82 MILLION


Further company coverage:  002399.SZ 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Shenzhen Hepalink Pharmaceutical Co

See all news